Researchers are exploring the use of modified microorganisms to both manufacture and deliver anticancer drugs.
This approach aims to improve drug delivery and potentially reduce side effects by utilizing bacteria as tiny, mobile factories. The research, published in *Nature* on September 9, 2026, details how these microorganisms can be engineered to produce therapeutic compounds directly within the body.
This method could offer a new way to treat cancer, leveraging the natural abilities of bacteria for medical applications.
Read the original coverage
💬 Comments
📜 Comment Policy